Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 19, 2013
Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs
Sara Carlert, Hans Lennernäs, Bertil Abrahamsson
Molecular Pharmaceutics
|
September 8, 2012
In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug
Sara Carlert, Pernilla Akesson, Gunilla Jerndal, et al.
Soft Matter
|
February 28, 2025
On the Ostwald ripening of crystalline and amorphous nanoparticles
Manja Annette Behrens, Alexandra Franzén, Sara Carlert, et al.
Advanced Drug Delivery Reviews
|
July 9, 2026
Enabling formulations for PROTACs: A line-of-sight to clinic
Magda Swedrowska, Rebecca Fransson, Esther Jacobs, et al.
Journal of Pharmaceutical Sciences
|
September 18, 2016
Biopharmaceutic Profiling of Salts to Improve Absorption of Poorly Soluble Basic Drugs
Christer Tannergren, Eva Karlsson, Kalle Sigfridsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 28, 2023
A comparison of USP 2 and µDISS Profiler™ apparatus for studying dissolution phenomena of ibuprofen and its salts
Laurin Zöller, Alex Avdeef, Eva Karlsson, et al.
Pharmaceutical Research
|
August 19, 2010
Predicting intestinal precipitation--a case example for a basic BCS class II drug
Sara Carlert, Anna Pålsson, Gunilla Hanisch, et al.
Molecular Pharmaceutics
|
September 22, 2025
Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies
Helena Engman, Sara Carlert, Maria Hammarberg, et al.
British Journal of Clinical Pharmacology
|
February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284
Sara Asimus, Robert Palmér, Muna Albayaty, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 31, 2013
In vitro models for the prediction of in vivo performance of oral dosage forms
Edmund S Kostewicz, Bertil Abrahamsson, Marcus Brewster, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 19, 2013
Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs
Sara Carlert, Hans Lennernäs, Bertil Abrahamsson
Molecular Pharmaceutics
|
September 8, 2012
In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug
Sara Carlert, Pernilla Akesson, Gunilla Jerndal, et al.
Soft Matter
|
February 28, 2025
On the Ostwald ripening of crystalline and amorphous nanoparticles
Manja Annette Behrens, Alexandra Franzén, Sara Carlert, et al.
Advanced Drug Delivery Reviews
|
July 9, 2026
Enabling formulations for PROTACs: A line-of-sight to clinic
Magda Swedrowska, Rebecca Fransson, Esther Jacobs, et al.
Journal of Pharmaceutical Sciences
|
September 18, 2016
Biopharmaceutic Profiling of Salts to Improve Absorption of Poorly Soluble Basic Drugs
Christer Tannergren, Eva Karlsson, Kalle Sigfridsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 28, 2023
A comparison of USP 2 and µDISS Profiler™ apparatus for studying dissolution phenomena of ibuprofen and its salts
Laurin Zöller, Alex Avdeef, Eva Karlsson, et al.
Pharmaceutical Research
|
August 19, 2010
Predicting intestinal precipitation--a case example for a basic BCS class II drug
Sara Carlert, Anna Pålsson, Gunilla Hanisch, et al.
Molecular Pharmaceutics
|
September 22, 2025
Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies
Helena Engman, Sara Carlert, Maria Hammarberg, et al.
British Journal of Clinical Pharmacology
|
February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284
Sara Asimus, Robert Palmér, Muna Albayaty, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 31, 2013
In vitro models for the prediction of in vivo performance of oral dosage forms
Edmund S Kostewicz, Bertil Abrahamsson, Marcus Brewster, et al.
Page
of 2